These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30529125)

  • 1. Cystic Fibrosis: Advancing Along the Continuum.
    Bono-Neri F; Romano C; Isedeh A
    J Pediatr Health Care; 2019; 33(3):242-254. PubMed ID: 30529125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
    Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
    Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis infant care challenges in diagnosis and management in the era of newborn screening.
    Padman R; Flathers K; Passi V
    Del Med J; 2012 May; 84(5):149-55. PubMed ID: 22866385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging issues in cystic fibrosis newborn screening.
    Castellani C; Massie J
    Curr Opin Pulm Med; 2010 Nov; 16(6):584-90. PubMed ID: 20814308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Cystic Fibrosis.
    Goetz D; Ren CL
    Pediatr Ann; 2019 Apr; 48(4):e154-e161. PubMed ID: 30986316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnicity impacts the cystic fibrosis diagnosis: A note of caution.
    Bosch B; Bilton D; Sosnay P; Raraigh KS; Mak DYF; Ishiguro H; Gulmans V; Thomas M; Cuppens H; Amaral M; De Boeck K
    J Cyst Fibros; 2017 Jul; 16(4):488-491. PubMed ID: 28233695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweat chloride testing: controversies and issues.
    Kharrazi M; Milla C; Wine J
    Lancet Respir Med; 2016 Aug; 4(8):605-607. PubMed ID: 27511631
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of Cystic Fibrosis in Nonscreened Populations.
    Sosnay PR; White TB; Farrell PM; Ren CL; Derichs N; Howenstine MS; Nick JA; De Boeck K
    J Pediatr; 2017 Feb; 181S():S52-S57.e2. PubMed ID: 28129813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and family issues regarding genetic testing for cystic fibrosis: a review of prenatal carrier testing and newborn screening.
    Sparbel KJ; Tluczek A
    Annu Rev Nurs Res; 2011; 29():303-29. PubMed ID: 22891510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis of cystic fibrosis.
    De Boeck K; Vermeulen F; Dupont L
    Presse Med; 2017 Jun; 46(6 Pt 2):e97-e108. PubMed ID: 28576637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U; Moatter T
    J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
    Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
    World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign and Deleterious Cystic Fibrosis Transmembrane Conductance Regulator Mutations Identified by Sequencing in Positive Cystic Fibrosis Newborn Screen Children from California.
    Salinas DB; Sosnay PR; Azen C; Young S; Raraigh KS; Keens TG; Kharrazi M
    PLoS One; 2016; 11(5):e0155624. PubMed ID: 27214204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From gene to disease; from defective chloride ion transport to cystic fibrosis].
    Scheffer H; van den Ouweland AM; Veeze HJ
    Ned Tijdschr Geneeskd; 2001 Apr; 145(14):686-7. PubMed ID: 11530706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.